Scott Clayton

Scott is an associate editor at TSI Network. He is the lead reporter and analyst for Dividend Advisor, Power Growth Investor and Canadian Wealth Advisor and a member of the Investment Planning Committee. Scott began his investment and financial career working with Pat McKeough at The Investment Reporter in the 1980s. Subsequently, he worked at the Financial Post Corporation Service for 10 years. He joined TSI Network in 1998. He is a Bachelor of Economics graduate of York University, and he also has an M.B.A. from the Schulich School of Business.

Posts by the author
For our December issue of TSI Dividend Advisor we reported on Pfizer’s research spending and recent acquisitions. They will contribute significantly to its future growth.

PFIZER INC. $31 (New York symbol PFE; Income Portfolio, Manufacturing & Industry sector; Shares o/s: 6.1 billion; Market cap: $189.1 billion; Price-to-sales ratio: 3.6; Dividend Sustainability Rating: Highest; Dividend yield: 3.9%; www.pfizer.com) is one of the world’s leading prescription drugmakers....
Recently, TSI Dividend Advisor reported on TransCanada’s completed acquisition of U.S.-based Columbia Pipeline Group. Combined with other projects underway, Columbia’s operations have spurred the company’s revenue and earnings, and should give TransCanada more cash for dividends....
Canadian bank dividends are the top reasons for investing in Canadian banks
Canadian REIT’s higher rents and occupancy levels lifted cash flow in the latest quarter as the trust continued to plan for 12 new developments.
Sun Life Financial increased its quarterly dividend 3.8% following acquisition of Assurant Inc., which will expand the insurer’s employee benefits programs.
Retailer North West Co. saw sales and earnings jump in the latest quarter despite oil industry layoffs in its Canadian and Alaska markets.
TD Bank’s U.S. operation helped to lift overall earnings despite a 55% jump in loan-loss provisions and slowing business in Western Canada.
These Two Top ETFs offer exposure to some of the best-performing blue chip stocks from around the world at a low fee.
Brookfield Renewable Partners will expand its generating capacity, revenue and cash flow with a $625 million investment in Colombia’s Isagen SA.